首页> 美国卫生研究院文献>Elsevier Sponsored Documents >A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23 CRUK 05/014 ISRCTN 53643604)

【2h】

A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23 CRUK 05/014 ISRCTN 53643604)

机译：预后不良的生殖细胞肿瘤的密集诱导化学疗法（CBOP / BEP）和标准BEP的随机2期试验（MRC TE23CRUK 05/014ISRCTN 53643604）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundStandard chemotherapy for poor-prognosis metastatic nonseminoma has remained bleomycin, etoposide, and cisplatin (BEP) for many years; more effective regimens are required.

机译：背景用于预后不良的转移性非精原细胞瘤的标准化学疗法多年来一直使用博来霉素，依托泊苷和顺铂（BEP）治疗。需要更有效的治疗方案。

著录项

期刊名称 Elsevier Sponsored Documents
作者
Robert A. Huddart; Rhian Gabe; Fay H. Cafferty; Philip Pollock; Jeff D. White; Jonathan Shamash; Michael H. Cullen; Sally P. Stenning;
展开▼
作者单位

展开▼
年(卷),期 -1(67),3
年度 -1
页码 534–543
总页数 10
原文格式 PDF
正文语种
中图分类
关键词
Metastatic germ cell tumour Poor prognosis Randomised trial;

机译：转移性生殖细胞肿瘤;预后不良;随机试验;
入库时间 2022-08-21 11:00:34

相似文献

外文文献

1. A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604) [J] . Huddart Robert A., Gabe Rhian, Cafferty Fay H., European urology . 2015,第3期

机译：预后不良的生殖细胞肿瘤的密集诱导化学疗法（CBOP / BEP）和标准BEP的随机2期试验（MRC TE23，CRUK 05/014，ISRCTN 53643604）
2. A randomised phase 2 trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor-prognosis germ cell tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604) [J] . Robert A. Huddart, Jeff D. White, Jonathan Shamash, Indian heart journal . 2015,第3期

机译：一种随机相2试验强化诱导化疗（CBOP / BEP）和标准BEP在差的预后细胞瘤中（MRC TE23，CRUK 05/014，ISRCTN 53643604）
3. Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604) [J] . Cafferty Fay H., White Jeff D., Shamash Jonathan, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2020,第期

机译：具有强化诱导化疗的长期成果（卡铂，博尔霉素，长霉素和顺铂，依托磷脂和顺铂）和标准博来霉素，依托磷脂在预后差异细胞肿瘤中的标准博霉素：随机期II试验（ISRCTN53643604）
4. Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours [O] . Nicola J. Lawrence, Howard Chan, Guy Toner, 2018

机译：P3BEP试验的方案（ANZUP 1302）：一项针对中度和低度转移性生殖细胞肿瘤的成年和儿科男性和女性患者的加速与标准BEP化疗的国际随机3期试验
5. A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604) [O] . Huddart Robert A., Gabe Rhian, Cafferty Fay H., 2015

机译：预后不良的生殖细胞肿瘤的密集诱导化学疗法（CBOP / BEP）和标准BEP的随机2期试验（MRC TE23，CRUK 05/014，ISRCTN 53643604）

A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23 CRUK 05/014 ISRCTN 53643604)

摘要

著录项

相似文献

相关主题

期刊订阅